Robert G. Holloway Jr., MD, MPH, is Professor and Edward A. and Alma Vollertsen Rykenboer Chair of the Department of Neurology at the University of Rochester School of Medicine and Dentistry. He received his undergraduate (1985) and medical degrees from the University of Connecticut (1989), and his neurology (1993) and health services research training (MPH, 1996) at the University of Rochester. He has been on the faculty since 1993 and became Chair in 2013.

Dr. Holloway is boarded in both Neurology and Palliative Medicine. His research interests are broad and include experimental therapeutics and outcomes research covering many areas of neurology. He is the PI on several institutional awards that support clinical trial research and career development. He has authored more than 200 manuscripts, reviews, and editorials, and is co-editor of two books: Case Studies in Neuroscience and Neuropalliative Care. He has been the recipient of numerous awards including the C. Miller Fisher Neuroscience Visionary Award, American Stroke Association, Dr. Robert Joynt Kindness Award, Junior Faculty Mentoring Award, Alpha Omega Alpha Faculty Inductee, Nominee, AAMC Humanism Award, and the Harry L. Segal Prize for Excellence in Third Year Teaching.

Certified Specialties

Hospice and Palliative Medicine - American Board of Internal Medicine

Neurology - American Board of Psychiatry & Neurology

Faculty Appointments

Professor - Department of Neurology (SMD)

Chair - Department of Neurology (SMD)

Edward A. and Alma Vollertsen Rykenboer Chair in Neurophysiology - Department of Neurology (SMD)

Credentials

Residency & Fellowship

Fellowship, Internal Medicine, Neurology, University of Rochester Medical Center. 1993 - 1996

Residency, Neurology, University of Rochester Medical Center. 1990 - 1993

Internship, Internal Medicine, University of Connecticut Health Center. 1989 - 1990

Education

MD | University of Connecticut School of Medicine. 1989

Awards

Alpha Omega Alpha Faculty Inductee. 2011

Junior Faculty Mentoring Award. 2008

Best Doctors in America. 2007 - 2012

Neurology Senior Faculty Teaching Award. 2006

Leadership Development for Physicians in Academic Health Centers. 2006

Nominee. 2006

Co-Chair. 2006

Medical Center Board Excellence Award. 2005

Teacher Recognition Award. 2004

Harry L. Segal Prize for Excellence in Third Year Teaching. 2002 - 2003

Neurology Faculty Teaching Award. 2002 - 2003

ISTAHC Award for 1997 for finest article published in 1997
" Mushlin AI, Mooney C, Holloway RG, Detsky AS, Mattson DH, Phelps CE. The cost-effectiveness of magnetic resonance imaging in patients with equivocal neurological symptoms. Int J Technol Assess Health Care, 1997:13:21-34. 1998

Quality Achievement Award for Physician Leadership in Performance Improvement. 1998

Phi Beta Kappa. 1985

Olin Award for Excellence in Undergraduate Research in Cellular and Molecular Biology. 1985

University Scholar. 1984

Research

Experimental Therapeutics of Neurological Disease
The neurology community has seen extraordinary successes and tremendous breakthroughs
in the treatment of neurological disorders. Translating these advances into improved clinical
care for patients requires a cadre of specialty-trained clinician neuroscientists who are to be
responsive to the increasing pace of scientific discoveries, as well as to the emerging suite of
approaches and techniques. This program will train the next generation of leaders in the
experimental therapeutics of neurological disease, to accelerate therapeutic
development and improve access to emerging breakthroughs for all patients and families who
may benefit.

NeuroNext
Rigorous clinical trials are essential for the translation of scientific discoveries to improve the health of children and adults with neurological diseases. The University of Rochester and its neuroscience investigators have the clinical trials experience, expertise, and track record to serve as an exemplary and high-quality Clinical Site to ensure the success of NeuroNEXT

Publications

Journal Articles

Palliative and End-of-Life Care in Stroke: A Scientific Statement From the American Heart Association.

Creutzfeldt CJ, Bu J, Comer A, Enguidanos S, Lutz B, Robinson MT, Zahuranec DB, Holloway RG,

Stroke.. 2024 December 16 Epub 12/16/2024.

Ira Shoulson, MD (1946-2024).

Dorsey ER, Holloway RG, Kieburtz K, Griggs RC

Neurology.. 2024 October 22103 (8):e209892. Epub 09/19/2024.

Navigating Neurologic Illness: Skills in Neuropalliative Care for Persons Hospitalized with Neurologic Disease.

Huang AP, Holloway RG

Seminars in neurology.. 2024 October 44 (5):503-513. Epub 07/25/2024.

Medical Forecasting-A Skill Set Worthy of Attention.

Creutzfeldt CJ, Holloway RG

JAMA neurology.. 2024 August 181 (8):791-792. Epub 1900 01 01.

Seven Strategies to Integrate Equity within Translational Research in Neurology.

Lizarraga KJ, Gyang T, Benson RT, Birbeck GL, Johnston KC, Royal W, Sacco RL, Segal B, Vickrey BG, Griggs RC, Holloway RG

Annals of neurology.. 2024 March 95 (3):432-441. Epub 01/25/2024.

Impact of the COVID-19 Pandemic on Inpatient Utilization for Acute Neurologic Disease.

Yoo A, Guterman EL, Hwang DY, Holloway RG, George BP

The Neurohospitalist.. 2024 January 14 (1):13-22. Epub 08/17/2023.

Return of individual research results to participants with and at risk for Parkinson's disease.

Lettenberger SE, Hartman EA, Tam K, Auinger P, Pawlik ME, Wilson R, Banda ET, Valdovinos B, Kinel D, Alcalay RN, Dorsey ER, Norcliffe-Kaufmann L, Sharma S, Holloway RG, Schneider RB

Journal of clinical and translational science.. 2024 8 (1):e164. Epub 10/15/2024.

Neuropalliative Care for Stroke Providers.

Creutzfeldt CJ, Abedini NC, Holloway RG

Stroke.. 2023 November 54 (11):e485-e487. Epub 10/10/2023.

National Cost Estimates of Invasive Mechanical Ventilation and Tracheostomy in Acute Stroke, 2008-2017.

Albert GP, McHugh DC, Hwang DY, Creutzfeldt CJ, Holloway RG, George BP

Stroke.. 2023 October 54 (10):2602-2612. Epub 09/14/2023.

Hospital Discharge and Readmissions Before and During the COVID-19 Pandemic for California Acute Stroke Inpatients.

Albert GP, McHugh DC, Roberts DE, Kelly AG, Okwechime R, Holloway RG, George BP

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.. 2023 August 32 (8):107233. Epub 06/23/2023.

Global neurology: It's time to take notice.

Rutkove SB, Poduri A, Holloway RG, Pomeroy SL, McArthur JC

Annals of clinical and translational neurology.. 2023 May 10 (5):842-845. Epub 03/23/2023.

Identification of Palliative Care Needs and Mental Health Outcomes Among Family Members of Patients With Severe Acute Brain Injury.

Plinke WV, Buchbinder SA, Brumback LC, Longstreth WT, Kiker WA, Holloway RG, Engelberg RA, Curtis JR, Creutzfeldt CJ

JAMA network open.. 2023 April 36 (4):e239949. Epub 04/03/2023.

Skilled Nursing Facility Participation in Bundled Payments Was Related to Small Increases in Nurse Staffing Levels.

Ying M, Temkin-Greener H, Thirukumaran CP, Joynt Maddox KE, Holloway RG, Li Y

Journal of applied gerontology : the official journal of the Southern Gerontological Society.. 2023 March 42 (3):456-463. Epub 11/02/2022.

Association of Skilled Nursing Facility Participation in Voluntary Bundled Payments With Postacute Care Outcomes for Joint Replacement.

Ying M, Thirukumaran CP, Temkin-Greener H, Joynt Maddox KE, Holloway RG, Li Y

Medical care.. 2023 February 161 (2):109-116. Epub 12/12/2022.

Emerging Subspecialties in Neurology: Cortical Careers in Neuropalliative Care.

Ng M, McFarlin J, Holloway RG, Miyasaki J, Kramer NM

Neurology.. 2023 January 17100 (3):158-161. Epub 10/20/2022.

Advancing the Neuropalliative Care Approach-A Call to Action.

Holloway RG, Kramer NM

JAMA neurology.. 2023 January 180 (1):7-8. Epub 1900 01 01.

Effect of COVID-19 pandemic on outcomes in intracerebral hemorrhage.

McHugh DC, Gershteyn A, Boerman C, Holloway RG, Roberts DE, George BP

PloS one.. 2023 18 (4):e0284845. Epub 04/26/2023.

A Remote Longitudinal Observational Study of Individuals at Genetic Risk for Parkinson Disease: Baseline Results.

Jensen-Roberts S, Myers TL, Auinger P, Cannon P, Rowbotham HM, Coker D, Chanoff E, Soto J, Pawlik M, Amodeo K, Sharma S, Valdovinos B, Wilson R, Sarkar A, McDermott MP, Alcalay RN, Biglan K, Kinel D, Tanner C, Winter-Evans R, Augustine EF, Holloway RG, Dorsey ER, Schneider RB

Neurology. Genetics.. 2022 October 8 (5):e200008. Epub 08/11/2022.

Reversal of Advanced Directives in Neurologic Emergencies.

McHugh DC, George BP, Bender MT, Horowitz RK, Kaufman DC, Holloway RG, Roberts DE

The Neurohospitalist.. 2022 October 12 (4):651-658. Epub 06/15/2022.

Association of Time Elapsed Since Ischemic Stroke With Risk of Recurrent Stroke in Older Patients Undergoing Elective Nonneurologic, Noncardiac Surgery.

Glance LG, Benesch CG, Holloway RG, Thirukumaran CP, Nadler JW, Eaton MP, Fleming FJ, Dick AW

JAMA surgery.. 2022 August 1157 (8):e222236. Epub 08/10/2022.

A Multi-Component Transition of Care Improvement Project to Reduce Hospital Readmissions Following Ischemic Stroke.

Leonhardt-Caprio AM, Sellers CR, Palermo E, Caprio TV, Holloway RG

The Neurohospitalist.. 2022 April 12 (2):205-212. Epub 08/05/2021.

Development and Dissemination of a Neurology Palliative Care Curriculum: Education in Palliative and End-of-Life Care Neurology.

Kluger BM, Kramer NM, Katz M, Galifianakis NB, Pantilat S, Long J, Vaughan CL, Foster LA, Creutzfeldt CJ, Holloway RG, Sillau S, Hauser J

Neurology. Clinical practice.. 2022 April 12 (2):176-182. Epub 1900 01 01.

Association of Medicare Mandatory Bundled Payment Reform With Joint Replacement Surgery Use for Beneficiaries With Alzheimer Disease and Related Dementias.

Thirukumaran CP, Ricciardi BF, Cai X, Holloway RG, Li Y, Glance LG

JAMA health forum.. 2022 February 3 (2):e215111. Epub 02/11/2022.

Skilled Nursing Facility Participation in a Voluntary Medicare Bundled Payment Program: Association With Facility Financial Performance.

Ying M, Temkin-Greener H, Thirukumaran CP, Joynt Maddox KE, Holloway RG, Li Y

Medical care.. 2022 January 160 (1):83-92. Epub 1900 01 01.

Recruitment for Remote Decentralized Studies in Parkinson's Disease.

Myers TL, Augustine EF, Baloga E, Daeschler M, Cannon P, Rowbotham H, Chanoff E, , Jensen-Roberts S, Soto J, Holloway RG, Marras C, Tanner CM, Ray Dorsey E, Schneider RB

Journal of Parkinson's disease.. 2022 12 (1):371-380. Epub 1900 01 01.

Prognostication in neurology.

Risco JR, Kelly AG, Holloway RG

Handbook of clinical neurology.. 2022 190 :175-193. Epub 1900 01 01.

Assessment of Discordance Between Physicians and Family Members Regarding Prognosis in Patients With Severe Acute Brain Injury.

Kiker WA, Rutz Voumard R, Andrews LIB, Holloway RG, Brumback LC, Engelberg RA, Curtis JR, Creutzfeldt CJ

JAMA network open.. 2021 October 14 (10):e2128991. Epub 10/01/2021.

Predictors of Surrogate Decision Makers Selecting Life-Sustaining Therapy for Severe Acute Brain Injury Patients: An Analysis of US Population Survey Data.

Garg A, Soto AL, Knies AK, Kolenikov S, Schalk M, Hammer H, White DB, Holloway RG, Sheth KN, Fraenkel L, Hwang DY

Neurocritical care.. 2021 October 35 (2):468-479. Epub 02/23/2021.

Perioperative Neurological Evaluation and Management to Lower the Risk of Acute Stroke in Patients Undergoing Noncardiac, Nonneurological Surgery: A Scientific Statement From the American Heart Association/American Stroke Association.

Benesch C, Glance LG, Derdeyn CP, Fleisher LA, Holloway RG, Messé SR, Mijalski C, Nelson MT, Power M, Welch BG,

Circulation.. 2021 May 11143 (19):e923-e946. Epub 04/08/2021.

Joy, Suffering, and the Goals of Medicine.

Kluger BM, Garvan CW, Holloway RG

JAMA neurology.. 2021 March 178 (3):265-266. Epub 1900 01 01.

Proceedings from the Neurotherapeutics Symposium on Neurological Emergencies: Shaping the Future of Neurocritical Care.

Simpkins AN, Busl KM, Amorim E, Barnett-Tapia C, Cervenka MC, Dhakar MB, Etherton MR, Fung C, Griggs R, Holloway RG, Kelly AG, Khan IR, Lizarraga KJ, Madagan HG, Onweni CL, Mestre H, Rabinstein AA, Rubinos C, Dionisio-Santos DA, Youn TS, Merck LH, Maciel CB,

Neurocritical care.. 2020 December 33 (3):636-645. Epub 09/21/2020.

Neuropalliative care essentials for the COVID-19 crisis.

Kluger BM, Vaughan CL, Robinson MT, Creutzfeldt C, Subramanian I, Holloway RG

Neurology.. 2020 September 195 (9):394-398. Epub 06/26/2020.

Medicare Shared Savings Program and readmission rate among patients with ischemic stroke.

Kim Y, Glance LG, Holloway RG, Li Y

Neurology.. 2020 August 2595 (8):e1071-e1079. Epub 06/17/2020.

Delirium disorder: Integrating delirium and acute encephalopathy.

Oldham MA, Holloway RG

Neurology.. 2020 July 2895 (4):173-178. Epub 06/09/2020.

Seven-Year Experience From the National Institute of Neurological Disorders and Stroke-Supported Network for Excellence in Neuroscience Clinical Trials.

Cudkowicz M, Chase MK, Coffey CS, Ecklund DJ, Thornell BJ, Lungu C, Mahoney K, Gutmann L, Shefner JM, Staley KJ, Bosch M, Foster E, Long JD, Bayman EO, Torner J, Yankey J, Peters R, Huff T, Conwit RA, , Shinnar S, Patch D, Darras BT, Ellis A, Packer RJ, Marder KS, Chiriboga CA, Henchcliffe C, Moran JA, Nikolov B, Factor SA, Seeley C, Greenberg SM, Amato AA, DeGregorio S, Simuni T, Ward T, Kissel JT, Kolb SJ, Bartlett A, Quinn JF, Keith K, Levine SR, Gilles N, Coyle PK, Lamb J, Wolfe GI, Crumlish A, Mejico L, Iqbal MM, Bowen JD, Tongco C, Nabors LB, Bashir K, Benge M, McDonald CM, Henricson EK, Oskarsson B, Dobkin BH, Canamar C, Glauser TA, Woo D, Molloy A, Clark P, Vollmer TL, Stein AJ, Barohn RJ, Dimachkie MM, Le Pichon JB, Benatar MG, Steele J, Wechsler L, Clemens PR, Amity C, Holloway RG, Annis C, Goldberg MP, Andersen M, Iannaccone ST, Smith AG, Singleton JR, Doudova M, Haley EC, Quigg MS, Lowenhaupt S, Malow BA, Adkins K, Clifford DB, Teshome MA, Connolly N

JAMA neurology.. 2020 June 177 (6):755-763. Epub 1900 01 01.

Balancing Past vs Future Values in Decision-Making-Reply.

Creutzfeldt CJ, Holloway RG

JAMA.. 2020 May 19323 (19):1976. Epub 1900 01 01.

Concerns of surrogate decision makers for patients with acute brain injury: A US population survey.

Hwang DY, Knies AK, Mampre D, Kolenikov S, Schalk M, Hammer H, White DB, Holloway RG, Sheth KN, Fraenkel L

Neurology.. 2020 May 1294 (19):e2054-e2068. Epub 04/27/2020.

Palliative care and Parkinson's disease: outpatient needs and models of care over the disease trajectory.

Tarolli CG, Holloway RG

Annals of palliative medicine.. 2020 February 9 (Suppl 1):S44-S51. Epub 12/13/2019.

Symptom burden among individuals with Parkinson disease: A national survey.

Tarolli CG, Zimmerman GA, Auinger P, McIntosh S, Horowitz RK, Kluger BM, Dorsey ER, Holloway RG

Neurology. Clinical practice.. 2020 February 10 (1):65-72. Epub 11/18/2019.

Treatment Decisions for a Future Self: Ethical Obligations to Guide Truly Informed Choices.

Creutzfeldt CJ, Holloway RG

JAMA.. 2020 January 14323 (2):115-116. Epub 1900 01 01.

A Virtual Cohort Study of Individuals at Genetic Risk for Parkinson's Disease: Study Protocol and Design.

Schneider RB, Myers TL, Rowbotham HM, Luff MK, Amodeo K, Sharma S, Wilson R, Jensen-Roberts S, Auinger P, McDermott MP, Alcalay RN, Biglan K, Kinel D, Tanner C, Winter-Evans R, Augustine EF, Cannon P, , Holloway RG, Dorsey ER

Journal of Parkinson's disease.. 2020 10 (3):1195-1207. Epub 1900 01 01.

Common Data Elements for Unruptured Intracranial Aneurysms and Aneurysmal Subarachnoid Hemorrhage: Recommendations from the Working Group on Hospital Course and Acute Therapies-Proposal of a Multidisciplinary Research Group.

de Oliveira Manoel AL, van der Jagt M, Amin-Hanjani S, Bambakidis NC, Brophy GM, Bulsara K, Claassen J, Connolly ES, Hoffer SA, Hoh BL, Holloway RG, Kelly AG, Mayer SA, Nakaji P, Rabinstein AA, Vajkoczy P, Vergouwen MDI, Woo H, Zipfel GJ, Suarez JI,

Neurocritical care.. 2019 June 30 (Suppl 1):36-45. Epub 1900 01 01.

Incidental Findings in Radiographic Imaging for Inpatients with Acute Ischemic Stroke.

Doyle SJ, George BP, Holloway RG, Kelly AG

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.. 2018 November 27 (11):3131-3136. Epub 08/02/2018.

Post-acute care discharge delays for neurology inpatients: Opportunity to improve patient flow.

Roberts DE, Holloway RG, George BP

Neurology. Clinical practice.. 2018 August 8 (4):302-310. Epub 1900 01 01.

Neuropalliative care: Priorities to move the field forward.

Creutzfeldt CJ, Kluger B, Kelly AG, Lemmon M, Hwang DY, Galifianakis NB, Carver A, Katz M, Curtis JR, Holloway RG

Neurology.. 2018 July 3191 (5):217-226. Epub 06/27/2018.

Guideline: The AHA/ASA made 217 recommendations for early management of acute ischemic stroke in adults.

Kelly AG, Holloway RG

Annals of internal medicine.. 2018 June 19168 (12):JC63. Epub 1900 01 01.

Interfacility transfers for US ischemic stroke and TIA, 2006-2014.

George BP, Doyle SJ, Albert GP, Busza A, Holloway RG, Sheth KN, Kelly AG

Neurology.. 2018 May 190 (18):e1561-e1569. Epub 04/04/2018.

Variability in Gastrostomy Tube Placement for Intracerebral Hemorrhage Patients at US Hospitals.

Hwang DY, George BP, Kelly AG, Schneider EB, Sheth KN, Holloway RG

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.. 2018 April 27 (4):978-987. Epub 12/06/2017.

For-Profit Hospital Status and Carotid Artery Stent Utilization in US Hospitals Performing Carotid Revascularization.

Chandler JV, George BP, Kelly AG, Holloway RG

Stroke.. 2017 November 48 (11):3161-3164. Epub 09/22/2017.

Palliative Care in Neurology.

Robinson MT, Holloway RG

Mayo Clinic proceedings.. 2017 October 92 (10):1592-1601. Epub 1900 01 01.

Palliative and end-of-life care in glioblastoma: defining and measuring opportunities to improve care.

Hemminger LE, Pittman CA, Korones DN, Serventi JN, Ladwig S, Holloway RG, Mohile NA

Neuro-oncology practice.. 2017 September 4 (3):182-188. Epub 09/27/2016.

Raising the Alarm on Brain Attacks in Surgical Patients: Are We Doing Enough to Prevent and Treat Postoperative Strokes?

Glance LG, Holloway RG

Anesthesiology.. 2017 July 127 (1):3-5. Epub 1900 01 01.

The emerging partnership between palliative care and stroke.

Holloway RG, Bernat JL

Neurology. Clinical practice.. 2017 June 7 (3):191-193. Epub 1900 01 01.

Junior faculty core curriculum to enhance faculty development.

Guillet R, Holloway RG, Gross RA, Libby K, Shapiro JR

Journal of clinical and translational science.. 2017 April 1 (2):77-82. Epub 02/27/2017.

Timing of Percutaneous Endoscopic Gastrostomy for Acute Ischemic Stroke: An Observational Study From the US Nationwide Inpatient Sample.

George BP, Kelly AG, Albert GP, Hwang DY, Holloway RG

Stroke.. 2017 February 48 (2):420-427. Epub 12/13/2016.

Increasing Efficiency of Recruitment in Early Parkinson's Disease Trials: A Case Study Examination of the STEADY-PD III Trial.

Berk S, Greco BL, Biglan K, Kopil CM, Holloway RG, Meunier C, Simuni T

Journal of Parkinson's disease.. 2017 7 (4):685-693. Epub 1900 01 01.

Are patients with amyotrophic lateral sclerosis at risk of a therapeutic misconception?

Kim SY, Wilson R, De Vries R, Ryan KA, Holloway RG, Kieburtz K

Journal of medical ethics.. 2016 August 42 (8):514-8. Epub 03/10/2016.

Understanding the 'therapeutic misconception' from the research participant's perspective.

Kim SY, De Vries R, Holloway RG, Kieburtz K

Journal of medical ethics.. 2016 August 42 (8):522-3. Epub 05/04/2016.

The lack of documentation of preferences in a cohort of adults who died after ischemic stroke.

Robinson MT, Vickrey BG, Holloway RG, Chong K, Williams LS, Brook RH, Leng M, Parikh P, Zingmond DS

Neurology.. 2016 May 3186 (22):2056-62. Epub 04/08/2016.

Neurologists as primary palliative care providers: Communication and practice approaches.

Creutzfeldt CJ, Robinson MT, Holloway RG

Neurology. Clinical practice.. 2016 February 6 (1):40-48. Epub 1900 01 01.

Palliative Care: A Core Competency for Stroke Neurologists.

Creutzfeldt CJ, Holloway RG, Curtis JR

Stroke.. 2015 September 46 (9):2714-9. Epub 08/04/2015.

Predicting decline and survival in severe acute brain injury: the fourth trajectory.

Creutzfeldt CJ, Longstreth WT, Holloway RG

BMJ : British medical journal. 2015 August 6351 :h3904. Epub 08/06/2015.

Palliative Care Needs in the Neuro-ICU.

Creutzfeldt CJ, Engelberg RA, Healey L, Cheever CS, Becker KJ, Holloway RG, Curtis JR

Critical care medicine.. 2015 August 43 (8):1677-84. Epub 1900 01 01.

"It is not guaranteed that you will benefit": True but misleading?

Kim SY, Wilson R, De Vries R, Kim HM, Holloway RG, Kieburtz K

Clinical trials : journal of the Society for Clinical Trials.. 2015 August 12 (4):424-9. Epub 05/11/2015.

Patient Preferences and Surrogate Decision Making in Neuroscience Intensive Care Units.

Cai X, Robinson J, Muehlschlegel S, White DB, Holloway RG, Sheth KN, Fraenkel L, Hwang DY

Neurocritical care.. 2015 August 23 (1):131-41. Epub 1900 01 01.

Are therapeutic motivation and having one's own doctor as researcher sources of therapeutic misconception?

Kim SY, De Vries R, Parnami S, Wilson R, Kim HM, Frank S, Holloway RG, Kieburtz K

Journal of medical ethics.. 2015 May 41 (5):391-7. Epub 05/22/2014.

Could the High Prevalence of Therapeutic Misconception Partly Be a Measurement Problem?

Kim SY, Wilson R, De Vries R, Kim HM, Holloway RG, Kieburtz K

IRB.. 2015 37 (4):11-8. Epub 1900 01 01.

Racial/Ethnic differences in process of care and outcomes among patients hospitalized with intracerebral hemorrhage.

Xian Y, Holloway RG, Smith EE, Schwamm LH, Reeves MJ, Bhatt DL, Schulte PJ, Cox M, Olson DM, Hernandez AF, Lytle BL, Anstrom KJ, Fonarow GC, Peterson ED

Stroke.. 2014 November 45 (11):3243-50. Epub 09/11/2014.

Cost of deep brain stimulation for the treatment of Parkinson's disease by surgical stimulation sites.

Stroupe KT, Weaver FM, Cao L, Ippolito D, Barton BR, Burnett-Zeigler IE, Holloway RG, Vickrey BG, Simuni T, Follett KA

Movement disorders : official journal of the Movement Disorder Society.. 2014 November 29 (13):1666-74. Epub 09/15/2014.

Current practices in feeding tube placement for US acute ischemic stroke inpatients.

George BP, Kelly AG, Schneider EB, Holloway RG

Neurology.. 2014 September 283 (10):874-82. Epub 08/06/2014.

Ethical considerations in elective amputation after traumatic peripheral nerve injuries.

Smith JK, Myers KP, Holloway RG, Landau ME

Neurology. Clinical practice.. 2014 August 4 (4):280-286. Epub 1900 01 01.

Hemicraniectomy for middle-cerebral-artery stroke.

Kelly AG, Holloway RG

The New England journal of medicine.. 2014 June 12370 (24):2346-7. Epub 1900 01 01.

Palliative and end-of-life care in stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association.

Holloway RG, Arnold RM, Creutzfeldt CJ, Lewis EF, Lutz BJ, McCann RM, Rabinstein AA, Saposnik G, Sheth KN, Zahuranec DB, Zipfel GJ, Zorowitz RD,

Stroke.. 2014 June 45 (6):1887-916. Epub 03/27/2014.

Risk adjustment of ischemic stroke outcomes for comparing hospital performance: a statement for healthcare professionals from the American Heart Association/American Stroke Association.

Katzan IL, Spertus J, Bettger JP, Bravata DM, Reeves MJ, Smith EE, Bushnell C, Higashida RT, Hinchey JA, Holloway RG, Howard G, King RB, Krumholz HM, Lutz BJ, Yeh RW, , , , , ,

Stroke.. 2014 March 45 (3):918-44. Epub 01/23/2014.

Variation in do-not-resuscitate orders for patients with ischemic stroke: implications for national hospital comparisons.

Kelly AG, Zahuranec DB, Holloway RG, Morgenstern LB, Burke JF

Stroke.. 2014 March 45 (3):822-7. Epub 02/12/2014.

Ethical considerations in stroke patients.

Kelly AG, Sahin B, Holloway RG

Current opinion in neurology.. 2014 February 27 (1):61-5. Epub 1900 01 01.

Evidence-based research ethics and determinations of "engagement in research".

Wilson R, Kieburtz K, Holloway RG, Kim SY

IRB.. 2014 36 (2):10-3. Epub 1900 01 01.

Reading a cost-effectiveness or decision analysis study: Five things to consider.

Young KC, Kelly AG, Holloway RG

Neurology. Clinical practice.. 2013 October 3 (5):413-420. Epub 1900 01 01.

The evolving role and value of libraries and librarians in health care.

Sollenberger JF, Holloway RG

JAMA.. 2013 September 25310 (12):1231-2. Epub 1900 01 01.

Estimating and communicating prognosis in advanced neurologic disease.

Holloway RG, Gramling R, Kelly AG

Neurology.. 2013 February 1980 (8):764-72. Epub 1900 01 01.

Too important to fail.

Benesch CG, Holloway RG

Annals of neurology.. 2013 February 73 (2):153-4. Epub 1900 01 01.

Research participants' "irrational" expectations: common or commonly mismeasured?

Kim SY, de Vries R, Wilson R, Parnami S, Frank S, Kieburtz K, Holloway RG

IRB.. 2013 35 (1):1-9. Epub 1900 01 01.

Treatment decisions after severe stroke: uncertainty and biases.

Creutzfeldt CJ, Holloway RG

Stroke.. 2012 December 43 (12):3405-8. Epub 11/13/2012.

Sham surgery controls in Parkinson's disease clinical trials: views of participants.

Kim SY, De Vries R, Holloway RG, Wilson R, Parnami S, Kim HM, Frank S, Kieburtz K

Movement disorders : official journal of the Movement Disorder Society.. 2012 September 1527 (11):1461-5. Epub 08/23/2012.

Parkinson's disease medication use and costs following deep brain stimulation.

Weaver FM, Stroupe KT, Cao L, Holloway RG, Vickrey BG, Simuni T, Hendricks A, Ippolito D

Movement disorders : official journal of the Movement Disorder Society.. 2012 September 1527 (11):1398-403. Epub 09/13/2012.

Early stroke mortality, patient preferences, and the withdrawal of care bias.

Kelly AG, Hoskins KD, Holloway RG

Neurology.. 2012 August 2879 (9):941-4. Epub 1900 01 01.

Symptomatic and palliative care for stroke survivors.

Creutzfeldt CJ, Holloway RG, Walker M

Journal of general internal medicine.. 2012 July 27 (7):853-60. Epub 01/19/2012.

Challenges in assessing hospital-level stroke mortality as a quality measure: comparison of ischemic, intracerebral hemorrhage, and total stroke mortality rates.

Xian Y, Holloway RG, Pan W, Peterson ED

Stroke.. 2012 June 43 (6):1687-90. Epub 04/24/2012.

Evidence, preferences, recommendations--finding the right balance in patient care.

Quill TE, Holloway RG

The New England journal of medicine.. 2012 May 3366 (18):1653-5. Epub 1900 01 01.

Comparison of enrollees and decliners of Parkinson disease sham surgery trials.

Kim SY, Wilson RM, Kim HM, Holloway RG, De Vries RG, Frank SA, Kieburtz K

Movement disorders : official journal of the Movement Disorder Society.. 2012 April 27 (4):506-11. Epub 02/07/2012.

In lieu of flowers….

Holloway RG

Journal of palliative medicine.. 2011 December 14 (12):1348-9. Epub 1900 01 01.

Palliative care needs and symptom patterns of hospitalized elders referred for consultation.

Olden AM, Holloway R, Ladwig S, Quill TE, van Wijngaarden E

Journal of pain and symptom management.. 2011 September 42 (3):410-8. Epub 03/27/2011.

Cost-effectiveness of disease-modifying therapy for multiple sclerosis: a population-based study.

Noyes K, Bajorska A, Chappel A, Schwid SR, Mehta LR, Weinstock-Guttman B, Holloway RG, Dick AW

Neurology.. 2011 July 2677 (4):355-63. Epub 07/20/2011.

Getting to value in neurological care: a roadmap for academic neurology.

Holloway RG, Ringel SP

Annals of neurology.. 2011 June 69 (6):909-18. Epub 1900 01 01.

Pearls & Oy-sters: a stroke of luck: detecting type A aortic dissection by MRA.

Hyland MH, Holloway RG

Neurology.. 2011 February 2276 (8):e31-3. Epub 1900 01 01.

Racial differences in mortality among patients with acute ischemic stroke: an observational study.

Xian Y, Holloway RG, Noyes K, Shah MN, Friedman B

Annals of internal medicine.. 2011 February 1154 (3):152-9. Epub 1900 01 01.

Association between stroke center hospitalization for acute ischemic stroke and mortality.

Xian Y, Holloway RG, Chan PS, Noyes K, Shah MN, Ting HH, Chappel AR, Peterson ED, Friedman B

JAMA.. 2011 January 26305 (4):373-80. Epub 1900 01 01.

Association between stroke center hospitalization for acute ischemic stroke and mortality

Xian,Y.; Holloway,R. G.; Chan,P. S.; Noyes,K.; Shah,M. N.; Ting,H. H.; Chappel,A. R.; Peterson,E. D.; Friedman,B.;.

JAMA. 2011; 305(4): 373-380.

Racial differences in mortality among patients with acute ischemic stroke: an observational study

Xian,Y.; Holloway,R. G.; Noyes,K.; Shah,M. N.; Friedman,B.;.

Ann.Intern.Med. 2011; 154(3): 152-159.

Health state preferences and decision-making after malignant middle cerebral artery infarctions.

Kelly AG, Holloway RG

Neurology.. 2010 August 2475 (8):682-7. Epub 07/14/2010.

Is it research?: an increasingly common question.

Kim SY, Holloway RG

Neurology.. 2010 July 1375 (2):102-4. Epub 1900 01 01.

Treatment decisions after brain injury--tensions among quality, preference, and cost.

Holloway RG, Quill TE

The New England journal of medicine.. 2010 May 13362 (19):1757-9. Epub 1900 01 01.

Palliative care consultations in hospitalized stroke patients.

Holloway RG, Ladwig S, Robb J, Kelly A, Nielsen E, Quill TE

Journal of palliative medicine.. 2010 April 13 (4):407-12. Epub 1900 01 01.

Are quality improvements associated with the Get With the Guidelines-Coronary Artery Disease (GWTG-CAD) program sustained over time? A longitudinal comparison of GWTG-CAD hospitals versus non-GWTG-CAD hospitals.

Xian Y, Pan W, Peterson ED, Heidenreich PA, Cannon CP, Hernandez AF, Friedman B, Holloway RG, Fonarow GC,

American heart journal.. 2010 February 159 (2):207-14. Epub 1900 01 01.

Palliative care consultations in hospitalized stroke patients

Holloway,R. G.; Ladwig,S.; Robb,J.; Kelly,A.; Nielsen,E.; Quill,T. E.;.

J.Palliat.Med. 2010; 13(4): 407-412.

Treatment decisions after brain injury--tensions among quality, preference, and cost

Holloway,R. G.; Quill,T. E.;.

N.Engl.J.Med. 2010; 362(19): 1757-1759.

Health state preferences and decision-making after malignant middle cerebral artery infarctions

Kelly,A. G.; Holloway,R. G.;.

Neurology. 2010; 75(8): 682-687.

Is it research?: an increasingly common question

Kim,S. Y.; Holloway,R. G.;.

Neurology. 2010; 75(2): 102-104.

Treatment of malignant pleural effusion: PleuRx catheter or talc pleurodesis? A cost-effectiveness analysis

Olden,A. M.; Holloway,R.;.

J.Palliat.Med. 2010; 13(1): 59-65.

Xian,Y.; Pan,W.; Peterson,E. D.; Heidenreich,P. A.; Cannon,C. P.; Hernandez,A. F.; Friedman,B.; Holloway,R. G.; Fonarow,G. C.; GWTG Steering Committee and Hospitals;.

Am.Heart J. 2010; 159(2): 207-214.

A cost-effectiveness analysis of carotid artery stenting compared with endarterectomy

Young,K. C.; Holloway,R. G.; Burgin,W. S.; Benesch,C. G.;.

J.Stroke Cerebrovasc Dis. 2010; 19(5): 404-409.

A cost-effectiveness analysis of carotid artery stenting compared with endarterectomy.

Young KC, Holloway RG, Burgin WS, Benesch CG

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.. 2010 19 (5):404-9. Epub 1900 01 01.

Patient and organizational factors related to education and support use by Veterans with Parkinson's disease.

Pogoda TK, Cramer IE, Meterko M, Lin H, Hendricks A, Holloway RG, Charns MP

Movement disorders : official journal of the Movement Disorder Society.. 2009 October 1524 (13):1916-24. Epub 1900 01 01.

Financing of U.S. biomedical research and new drug approvals across therapeutic areas.

Dorsey ER, Thompson JP, Carrasco M, de Roulet J, Vitticore P, Nicholson S, Johnston SC, Holloway RG, Moses H

PloS one.. 2009 September 114 (9):e7015. Epub 09/11/2009.

Effects of gabapentin on sleep in menopausal women with hot flashes as measured by a Pittsburgh Sleep Quality Index factor scoring model.

Yurcheshen ME, Guttuso T, McDermott M, Holloway RG, Perlis M

Journal of women's health.. 2009 September 18 (9):1355-60. Epub 1900 01 01.

Selegiline shortage: Causes and costs of a generic drug shortage.

Dorsey ER, Thompson JP, Dayoub EJ, George B, Saubermann LA, Holloway RG

Neurology.. 2009 July 2173 (3):213-7. Epub 1900 01 01.

A review of the evidence for the use of telemedicine within stroke systems of care: a scientific statement from the American Heart Association/American Stroke Association.

Schwamm LH, Holloway RG, Amarenco P, Audebert HJ, Bakas T, Chumbler NR, Handschu R, Jauch EC, Knight WA, Levine SR, Mayberg M, Meyer BC, Meyers PM, Skalabrin E, Wechsler LR, ,

Stroke.. 2009 July 40 (7):2616-34. Epub 05/07/2009.

Funding of Parkinson research from industry and US federal and foundation sources.

Dorsey ER, Thompson JP, Frasier M, Sherer T, Fiske B, Nicholson S, Johnston SC, Holloway RG, Moses H

Movement disorders : official journal of the Movement Disorder Society.. 2009 April 1524 (5):731-7. Epub 1900 01 01.

When disclosures are more interesting than the evidence.

Holloway RG, Benesch C

Stroke.. 2009 February 40 (2):e44; author reply e45. Epub 12/18/2008.

Financing of U.S. biomedical research and new drug approvals across therapeutic areas

Dorsey,E. R.; Thompson,J. P.; Carrasco,M.; de Roulet,J.; Vitticore,P.; Nicholson,S.; Johnston,S. C.; Holloway,R. G.; Moses,H.,3rd;.

PLoS One. 2009; 4(9): e7015.

Funding of Parkinson research from industry and US federal and foundation sources

Dorsey,E. R.; Thompson,J. P.; Frasier,M.; Sherer,T.; Fiske,B.; Nicholson,S.; Johnston,S. C.; Holloway,R. G.; Moses,H.,3rd;.

Mov.Disord. 2009; 24(5): 731-737.

Utilization, diagnosis, treatment and cost of migraine treatment in the emergency department

Friedman,D.; Feldon,S.; Holloway,R.; Fisher,S.;.

Headache. 2009; 49(8): 1163-1173.

When disclosures are more interesting than the evidence

Holloway,R. G.; Benesch,C.;.

Stroke. 2009; 40(2): e44; author reply e45.

An approach to evaluating the therapeutic misconception

Kim,S. Y.; Schrock,L.; Wilson,R. M.; Frank,S. A.; Holloway,R. G.; Kieburtz,K.; de Vries,R. G.;.

IRB. 2009; 31(5): 7-14.

Patient and organizational factors related to education and support use by Veterans with Parkinson's disease

Pogoda,T. K.; Cramer,I. E.; Meterko,M.; Lin,H.; Hendricks,A.; Holloway,R. G.; Charns,M. P.;.

Mov.Disord. 2009; 24(13): 1916-1924.

A review of the evidence for the use of telemedicine within stroke systems of care: a scientific statement from the American Heart Association/American Stroke Association

Schwamm,L. H.; Holloway,R. G.; Amarenco,P.; Audebert,H. J.; Bakas,T.; Chumbler,N. R.; Handschu,R.; Jauch,E. C.; Knight,W. A.,4th; Levine,S. R.; Mayberg,M.; Meyer,B. C.; Meyers,P. M.; Skalabrin,E.; Wechsler,L. R.; American Heart Association Stroke Council; Interdisciplinary Council on Peripheral Vascular Disease;.

Stroke. 2009; 40(7): 2616-2634.

Effects of gabapentin on sleep in menopausal women with hot flashes as measured by a Pittsburgh Sleep Quality Index factor scoring model

Yurcheshen,M. E.; Guttuso,T.,Jr; McDermott,M.; Holloway,R. G.; Perlis,M.;.

J.Womens Health.(Larchmt). 2009; 18(9): 1355-1360.

An approach to evaluating the therapeutic misconception.

Kim SY, Schrock L, Wilson RM, Frank SA, Holloway RG, Kieburtz K, de Vries RG

IRB.. 2009 31 (5):7-14. Epub 1900 01 01.

Trust in early phase research: therapeutic optimism and protective pessimism.

Kim SY, Holloway RG, Frank S, Wilson R, Kieburtz K

Medicine, health care, and philosophy.. 2008 December 11 (4):393-401. Epub 07/16/2008.

Public reporting of quality data for stroke: is it measuring quality?

Kelly A, Thompson JP, Tuttle D, Benesch C, Holloway RG

Stroke.. 2008 December 39 (12):3367-71. Epub 09/04/2008.

Quantitative risk-benefit analysis of natalizumab.

Thompson JP, Noyes K, Dorsey ER, Schwid SR, Holloway RG

Neurology.. 2008 July 2971 (5):357-64. Epub 1900 01 01.

Invited Article: Conflicts of interest for authors of American Academy of Neurology clinical practice guidelines.

Holloway RG, Mooney CJ, Getchius TS, Edlund WS, Miyasaki JO

Neurology.. 2008 July 171 (1):57-63. Epub 1900 01 01.

Invited article: Neurology and quality improvement: an introduction.

Bever CT, Holloway RG, Iverson DJ, Dubinsky RM, Richardson RM, Sheffield JK, Wang DZ, Franklin GM, Miyasaki JM, Tonn ST, Stevens JC

Neurology.. 2008 April 2970 (18):1636-40. Epub 1900 01 01.

Ethics of sham surgery: perspective of patients.

Frank SA, Wilson R, Holloway RG, Zimmerman C, Peterson DR, Kieburtz K, Kim SY

Movement disorders : official journal of the Movement Disorder Society.. 2008 January 23 (1):63-8. Epub 1900 01 01.

Ethics of sham surgery: perspective of patients

Frank,S. A.; Wilson,R.; Holloway,R. G.; Zimmerman,C.; Peterson,D. R.; Kieburtz,K.; Kim,S. Y.;.

Mov.Disord. 2008; 23(1): 63-68.

Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results

Goetz,C. G.; Tilley,B. C.; Shaftman,S. R.; Stebbins,G. T.; Fahn,S.; Martinez-Martin,P.; Poewe,W.; Sampaio,C.; Stern,M. B.; Dodel,R.; Dubois,B.; Holloway,R.; Jankovic,J.; Kulisevsky,J.; Lang,A. E.; Lees,A.; Leurgans,S.; LeWitt,P. A.; Nyenhuis,D.; Olanow,C. W.; Rascol,O.; Schrag,A.; Teresi,J. A.; van Hilten,J. J.; LaPelle,N.; Movement Disorder Society UPDRS Revision Task Force;.

Mov.Disord. 2008; 23(15): 2129-2170.

Public reporting of quality data for stroke: is it measuring quality?

Kelly,A.; Thompson,J. P.; Tuttle,D.; Benesch,C.; Holloway,R. G.;.

Stroke. 2008; 39(12): 3367-3371.

Trust in early phase research: therapeutic optimism and protective pessimism

Kim,S. Y.; Holloway,R. G.; Frank,S.; Wilson,R.; Kieburtz,K.;.

Med.Health Care Philos. 2008; 11(4): 393-401.

A cost-utility comparison of four first-line medications in painful diabetic neuropathy

O'Connor,A. B.; Noyes,K.; Holloway,R. G.;.

Pharmacoeconomics. 2008; 26(12): 1045-1064.

A cost-utility comparison of four first-line medications in painful diabetic neuropathy.

O'Connor AB, Noyes K, Holloway RG

PharmacoEconomics.. 2008 26 (12):1045-64. Epub 1900 01 01.

Quality of life in epilepsy, multiple sclerosis, and beyond.

Dorsey ER, Holloway RG

Annals of neurology.. 2007 October 62 (4):307-8. Epub 1900 01 01.

Mortality as a measure of quality: implications for palliative and end-of-life care.

Holloway RG, Quill TE

JAMA.. 2007 August 15298 (7):802-4. Epub 1900 01 01.

A cost-effectiveness comparison of desipramine, gabapentin, and pregabalin for treating postherpetic neuralgia.

O'Connor AB, Noyes K, Holloway RG

Journal of the American Geriatrics Society.. 2007 August 55 (8):1176-84. Epub 1900 01 01.

Risk factors for somnolence, edema, and hallucinations in early Parkinson disease.

Biglan KM, Holloway RG, McDermott MP, Richard IH,

Neurology.. 2007 July 1069 (2):187-95. Epub 1900 01 01.

Proactive palliative care in the medical intensive care unit: effects on length of stay for selected high-risk patients.

Norton SA, Hogan LA, Holloway RG, Temkin-Greener H, Buckley MJ, Quill TE

Critical care medicine.. 2007 June 35 (6):1530-5. Epub 1900 01 01.

Quantifying the risks and benefits of natalizumab in relapsing multiple sclerosis.

Dorsey ER, Thompson JP, Noyes K, Dick AW, Holloway RG, Schwid SR

Neurology.. 2007 May 168 (18):1524-8. Epub 1900 01 01.

Health care costs decline after successful epilepsy surgery.

Langfitt JT, Holloway RG, McDermott MP, Messing S, Sarosky K, Berg AT, Spencer SS, Vickrey BG, Sperling MR, Bazil CW, Shinnar S

Neurology.. 2007 April 1768 (16):1290-8. Epub 1900 01 01.

Accuracy of Medicare claims data in identifying Parkinsonism cases: comparison with the Medicare current beneficiary survey.

Noyes K, Liu H, Holloway R, Dick AW

Movement disorders : official journal of the Movement Disorder Society.. 2007 March 1522 (4):509-14. Epub 1900 01 01.

Medical errors after stroke: preventable or inevitable?

Rizzo M, Glick TH

Neurology.. 2007 February 2068 (8):542-3. Epub 1900 01 01.

The safety of hospital stroke care.

Holloway RG, Tuttle D, Baird T, Skelton WK

Neurology.. 2007 February 2068 (8):550-5. Epub 1900 01 01.

Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030.

Dorsey ER, Constantinescu R, Thompson JP, Biglan KM, Holloway RG, Kieburtz K, Marshall FJ, Ravina BM, Schifitto G, Siderowf A, Tanner CM

Neurology.. 2007 January 3068 (5):384-6. Epub 11/02/2006.

Diffusion tensor imaging: scientific advance, clinical tool, or just a pretty picture?

Little DM, Holloway RG

Neurology.. 2007 January 268 (1):9-10. Epub 1900 01 01.

Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Process, format, and clinimetric testing plan.

Goetz CG, Fahn S, Martinez-Martin P, Poewe W, Sampaio C, Stebbins GT, Stern MB, Tilley BC, Dodel R, Dubois B, Holloway R, Jankovic J, Kulisevsky J, Lang AE, Lees A, Leurgans S, LeWitt PA, Nyenhuis D, Olanow CW, Rascol O, Schrag A, Teresi JA, Van Hilten JJ, LaPelle N

Movement disorders : official journal of the Movement Disorder Society.. 2007 January 22 (1):41-7. Epub 1900 01 01.

Risk factors for somnolence, edema, and hallucinations in early Parkinson disease

Biglan,K. M.; Holloway,R. G.,Jr; McDermott,M. P.; Richard,I. H.; Parkinson Study Group CALM-PD Investigators;.

Neurology. 2007; 69(2): 187-195.

Quality of life in epilepsy, multiple sclerosis, and beyond

Dorsey,E. R.; Holloway,R. G.;.

Ann.Neurol. 2007; 62(4): 307-308.

Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Process, format, and clinimetric testing plan

Goetz,C. G.; Fahn,S.; Martinez-Martin,P.; Poewe,W.; Sampaio,C.; Stebbins,G. T.; Stern,M. B.; Tilley,B. C.; Dodel,R.; Dubois,B.; Holloway,R.; Jankovic,J.; Kulisevsky,J.; Lang,A. E.; Lees,A.; Leurgans,S.; LeWitt,P. A.; Nyenhuis,D.; Olanow,C. W.; Rascol,O.; Schrag,A.; Teresi,J. A.; Van Hilten,J. J.; LaPelle,N.;.

Mov.Disord. 2007; 22(1): 41-47.

Mortality as a measure of quality: implications for palliative and end-of-life care

Holloway,R. G.; Quill,T. E.;.

JAMA. 2007; 298(7): 802-804.

The safety of hospital stroke care

Holloway,R. G.; Tuttle,D.; Baird,T.; Skelton,W. K.;.

Neurology. 2007; 68(8): 550-555.

Diffusion tensor imaging: scientific advance, clinical tool, or just a pretty picture?

Little,D. M.; Holloway,R. G.;.

Neurology. 2007; 68(1): 9-10.

Proactive palliative care in the medical intensive care unit: effects on length of stay for selected high-risk patients

Norton,S. A.; Hogan,L. A.; Holloway,R. G.; Temkin-Greener,H.; Buckley,M. J.; Quill,T. E.;.

Crit.Care Med. 2007; 35(6): 1530-1535.

The implications of using US-specific EQ-5D preference weights for cost-effectiveness evaluation

Noyes,K.; Dick,A. W.; Holloway,R. G.;.

Med.Decis.Making. 2007; 27(3): 327-334.

Accuracy of Medicare claims data in identifying Parkinsonism cases: comparison with the Medicare current beneficiary survey

Noyes,K.; Liu,H.; Holloway,R.; Dick,A. W.;.

Mov.Disord. 2007; 22(4): 509-514.

A cost-effectiveness comparison of desipramine, gabapentin, and pregabalin for treating postherpetic neuralgia

O'Connor,A. B.; Noyes,K.; Holloway,R. G.;.

J.Am.Geriatr.Soc. 2007; 55(8): 1176-1184.

The implications of using US-specific EQ-5D preference weights for cost-effectiveness evaluation.

Noyes K, Dick AW, Holloway RG

Medical decision making : an international journal of the Society for Medical Decision Making.. 2007 27 (3):327-34. Epub 05/14/2007.

Financial anatomy of neuroscience research.

Dorsey ER, Vitticore P, De Roulet J, Thompson JP, Carrasco M, Johnston SC, Holloway RG, Moses H

Annals of neurology.. 2006 December 60 (6):652-9. Epub 1900 01 01.

There is nothing staid about STARD: progress in the reporting of diagnostic accuracy studies.

Johnston KC, Holloway RG

Neurology.. 2006 September 1267 (5):740-1. Epub 1900 01 01.

Biomarkers in Parkinson's disease.

Dorsey ER, Holloway RG, Ravina BM

Expert review of neurotherapeutics.. 2006 June 6 (6):823-31. Epub 1900 01 01.

Volunteering for early phase gene transfer research in Parkinson disease.

Kim SY, Holloway RG, Frank S, Beck CA, Zimmerman C, Wilson R, Kieburtz K

Neurology.. 2006 April 1166 (7):1010-5. Epub 03/15/2006.

What is the risk of developing parkinsonism following neuroleptic use?

Noyes K, Liu H, Holloway RG

Neurology.. 2006 March 2866 (6):941-3. Epub 1900 01 01.

Update in neurology.

Holloway RG, Józefowicz RF

Annals of internal medicine.. 2006 March 21144 (6):421-6. Epub 1900 01 01.

Economic burden associated with Parkinson's disease on elderly Medicare beneficiaries.

Noyes K, Liu H, Li Y, Holloway R, Dick AW

Movement disorders : official journal of the Movement Disorder Society.. 2006 March 21 (3):362-72. Epub 1900 01 01.

Biomarkers in Parkinson's disease

Dorsey,E. R.; Holloway,R. G.; Ravina,B. M.;.

Expert Rev.Neurother. 2006; 6(6): 823-831.

Financial anatomy of neuroscience research

Dorsey,E. R.; Vitticore,P.; De Roulet,J.; Thompson,J. P.; Carrasco,M.; Johnston,S. C.; Holloway,R. G.; Moses,H.,3rd;.

Ann.Neurol. 2006; 60(6): 652-659.

Review: lorazepam provides the best control for status epilepticus

Henry,J. C.; Holloway,R.;.

Evid Based.Med. 2006; 11(2): 54.

Review: Lorazepam provides the best control for status epilepticus

Henry,J. C.; Holloway,R.;.

ACP J.Club. 2006; 144(2): 35.

Update in neurology

Holloway,R. G.,Jr; Jozefowicz,R. F.;.

Ann.Intern.Med. 2006; 144(6): 421-426.

There is nothing staid about STARD: progress in the reporting of diagnostic accuracy studies

Johnston,K. C.; Holloway,R. G.;.

Neurology. 2006; 67(5): 740-741.

Review: noninvasive imaging techniques may be useful for diagnosing 70% to 99% carotid stenosis in symptomatic patients

Kelly,A. G.; Holloway,R. G.;.

ACP J.Club. 2006; 145(3): 77.

Pramipexole versus levodopa in patients with early Parkinson's disease: effect on generic and disease-specific quality of life

Noyes,K.; Dick,A. W.; Holloway,R. G.; Parkinson Study Group;.

Value Health. 2006; 9(1): 28-38.

What is the risk of developing parkinsonism following neuroleptic use?

Noyes,K.; Liu,H.; Holloway,R. G.;.

Neurology. 2006; 66(6): 941-943.

Economic burden associated with Parkinson's disease on elderly Medicare beneficiaries

Noyes,K.; Liu,H.; Li,Y.; Holloway,R.; Dick,A. W.;.

Mov.Disord. 2006; 21(3): 362-372.

Pramipexole versus levodopa in patients with early Parkinson's disease: effect on generic and disease-specific quality of life.

Noyes K, Dick AW, Holloway RG,

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.. 2006 9 (1):28-38. Epub 1900 01 01.

Review: noninvasive imaging techniques may be useful for diagnosing 70% to 99% carotid stenosis in symptomatic patients.

Kelly AG, Holloway RG

ACP journal club.. 2006 145 (3):77. Epub 1900 01 01.

What is the risk of sham surgery in Parkinson disease clinical trials? A review of published reports.

Frank S, Kieburtz K, Holloway R, Kim SY

Neurology.. 2005 October 1165 (7):1101-3. Epub 07/20/2005.

Carotid endarterectomy--an evidence-based review: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.

Chaturvedi S, Bruno A, Feasby T, Holloway R, Benavente O, Cohen SN, Cote R, Hess D, Saver J, Spence JD, Stern B, Wilterdink J,

Neurology.. 2005 September 2765 (6):794-801. Epub 1900 01 01.

Science and ethics of sham surgery: a survey of Parkinson disease clinical researchers.

Kim SY, Frank S, Holloway R, Zimmerman C, Wilson R, Kieburtz K

Archives of neurology.. 2005 September 62 (9):1357-60. Epub 1900 01 01.

Prognosis and decision making in severe stroke.

Holloway RG, Benesch CG, Burgin WS, Zentner JB

JAMA.. 2005 August 10294 (6):725-33. Epub 1900 01 01.

How much is a good night's sleep worth?

Williams LS, Holloway RG

Stroke.. 2005 June 36 (6):1293-4. Epub 1900 01 01.

Responsiveness of life-threatening refractory emesis to gabapentin-scopolamine therapy following posterior fossa surgery. Case report.

Guttuso T, Vitticore P, Holloway RG

Journal of neurosurgery.. 2005 March 102 (3):547-9. Epub 1900 01 01.

The Canadian Stroke Quality of Care Study: establishing indicators for optimal acute stroke care.

Lindsay MP, Kapral MK, Gladstone D, Holloway R, Tu JV, Laupacis A, Grimshaw JM

CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.. 2005 February 1172 (3):363-5. Epub 1900 01 01.

The role of radiotracer imaging in Parkinson disease.

Ravina B, Eidelberg D, Ahlskog JE, Albin RL, Brooks DJ, Carbon M, Dhawan V, Feigin A, Fahn S, Guttman M, Gwinn-Hardy K, McFarland H, Innis R, Katz RG, Kieburtz K, Kish SJ, Lange N, Langston JW, Marek K, Morin L, Moy C, Murphy D, Oertel WH, Oliver G, Palesch Y, Powers W, Seibyl J, Sethi KD, Shults CW, Sheehy P, Stoessl AJ, Holloway R

Neurology.. 2005 January 2564 (2):208-15. Epub 1900 01 01.

Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society.

Holloway RG

Neurology.. 2005 January 1164 (1):172-4; author reply 172-4. Epub 1900 01 01.

What is the risk of sham surgery in Parkinson disease clinical trials? A review of published reports

Frank,S.; Kieburtz,K.; Holloway,R.; Kim,S. Y.;.

Neurology. 2005; 65(7): 1101-1103.

Responsiveness of life-threatening refractory emesis to gabapentin-scopolamine therapy following posterior fossa surgery. Case report

Guttuso,T.,Jr; Vitticore,P.; Holloway,R. G.;.

J.Neurosurg. 2005; 102(3): 547-549.

The Babinski sign: thumbs up or toes down?

Holloway,R.;.

Neurology. 2005; 65(8): 1147.

Timing and route of enteral tube-feeding did not reduce death or poor outcome in stroke and dysphagia

Holloway,R.;.

ACP J.Club. 2005; 143(2): 37.

Protein-energy supplementation of normal hospital diet did not improve outcomes after recent stroke

Holloway,R.;.

ACP J.Club. 2005; 143(2): 36.

Holloway,R. G.;.

Neurology. 2005; 64(1): 172-4; author reply 172-4.

Prognosis and decision making in severe stroke

Holloway,R. G.; Benesch,C. G.; Burgin,W. S.; Zentner,J. B.;.

JAMA. 2005; 294(6): 725-733.

Science and ethics of sham surgery: a survey of Parkinson disease clinical researchers

Kim,S. Y.; Frank,S.; Holloway,R.; Zimmerman,C.; Wilson,R.; Kieburtz,K.;.

Arch.Neurol. 2005; 62(9): 1357-1360.

The Canadian Stroke Quality of Care Study: establishing indicators for optimal acute stroke care

Lindsay,M. P.; Kapral,M. K.; Gladstone,D.; Holloway,R.; Tu,J. V.; Laupacis,A.; Grimshaw,J. M.;.

CMAJ. 2005; 172(3): 363-365.

Pramipexole and levodopa in early Parkinson's disease: dynamic changes in cost effectiveness

Noyes,K.; Dick,A. W.; Holloway,R. G.; Parkinson Study Group;.

Pharmacoeconomics. 2005; 23(12): 1257-1270.

How much is a good night's sleep worth?

Williams,L. S.; Holloway,R. G.;.

Stroke. 2005; 36(6): 1293-1294.

Pramipexole and levodopa in early Parkinson's disease: dynamic changes in cost effectiveness.

Noyes K, Dick AW, Holloway RG,

PharmacoEconomics.. 2005 23 (12):1257-70. Epub 1900 01 01.

Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: status and recommendations.

Goetz CG, Poewe W, Rascol O, Sampaio C, Stebbins GT, Counsell C, Giladi N, Holloway RG, Moore CG, Wenning GK, Yahr MD, Seidl L,

Movement disorders : official journal of the Movement Disorder Society.. 2004 September 19 (9):1020-8. Epub 1900 01 01.

Randomized pilot trial of high-dose betaINF-1a in patients with inclusion body myositis.

Neurology.. 2004 August 2463 (4):718-20. Epub 1900 01 01.

Teaching and evaluating first and second year medical students' practice of evidence-based medicine.

Holloway R, Nesbit K, Bordley D, Noyes K

Medical education.. 2004 August 38 (8):868-78. Epub 1900 01 01.

Electronic reporting to improve patient safety.

Tuttle D, Holloway R, Baird T, Sheehan B, Skelton WK

Quality & safety in health care.. 2004 August 13 (4):281-6. Epub 1900 01 01.

Pramipexole vs levodopa as initial treatment for Parkinson disease: a 4-year randomized controlled trial.

Holloway RG, Shoulson I, Fahn S, Kieburtz K, Lang A, Marek K, McDermott M, Seibyl J, Weiner W, Musch B, Kamp C, Welsh M, Shinaman A, Pahwa R, Barclay L, Hubble J, LeWitt P, Miyasaki J, Suchowersky O, Stacy M, Russell DS, Ford B, Hammerstad J, Riley D, Standaert D, Wooten F, Factor S, Jankovic J, Atassi F, Kurlan R, Panisset M, Rajput A, Rodnitzky R, Shults C, Petsinger G, Waters C, Pfeiffer R, Biglan K, Borchert L, Montgomery A, Sutherland L, Weeks C, DeAngelis M, Sime E, Wood S, Pantella C, Harrigan M, Fussell B, Dillon S, Alexander-Brown B, Rainey P, Tennis M, Rost-Ruffner E, Brown D, Evans S, Berry D, Hall J, Shirley T, Dobson J, Fontaine D, Pfeiffer B, Brocht A, Bennett S, Daigneault S, Hodgeman K, O'Connell C, Ross T, Richard K, Watts A,

Archives of neurology.. 2004 July 61 (7):1044-53. Epub 1900 01 01.

Evidence-based neurotherapeutics: a spectrum of evidence.

Holloway RG, Siderowf AD

NeuroRx : the journal of the American Society for Experimental NeuroTherapeutics.. 2004 July 1 (3):295-7. Epub 1900 01 01.

Evidence from cost-effectiveness research.

Noyes K, Holloway RG

NeuroRx : the journal of the American Society for Experimental NeuroTherapeutics.. 2004 July 1 (3):348-55. Epub 1900 01 01.

Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: status and recommendations

Goetz,C. G.; Poewe,W.; Rascol,O.; Sampaio,C.; Stebbins,G. T.; Counsell,C.; Giladi,N.; Holloway,R. G.; Moore,C. G.; Wenning,G. K.; Yahr,M. D.; Seidl,L.; Movement Disorder Society Task Force on Rating Scales for Parkinson's Disease;.

Mov.Disord. 2004; 19(9): 1020-1028.

Editorial comment--stroke cost-effectiveness research: are acceptability curves acceptable?

Holloway,R.; Dick,A. W.;.

Stroke. 2004; 35(1): 203-204.

Review: anticholinergic drugs improve motor function and disability in Parkinson disease

Holloway,R.; Frank,S.;.

ACP J.Club. 2004; 140(1): 15.

Teaching and evaluating first and second year medical students' practice of evidence-based medicine

Holloway,R.; Nesbit,K.; Bordley,D.; Noyes,K.;.

Med.Educ. 2004; 38(8): 868-878.

Evidence-based neurotherapeutics: a spectrum of evidence

Holloway,R. G.; Siderowf,A. D.;.

NeuroRx. 2004; 1(3): 295-297.

Pramipexole v. levodopa as initial treatment for Parkinson's disease: a randomized clinical-economic trial

Noyes,K.; Dick,A. W.; Holloway,R. G.; Parkinson Study Group;.

Med.Decis.Making. 2004; 24(5): 472-485.

Evidence from cost-effectiveness research

Noyes,K.; Holloway,R. G.;.

NeuroRx. 2004; 1(3): 348-355.

Pramipexole v. levodopa as initial treatment for Parkinson's disease: a randomized clinical-economic trial.

Noyes K, Dick AW, Holloway RG,

Medical decision making : an international journal of the Society for Medical Decision Making.. 2004 24 (5):472-85. Epub 1900 01 01.

Medical errors on an inpatient neurology service.

Frank S, Holloway R

Neurology.. 2003 July 2261 (2):254-7. Epub 1900 01 01.

Burdens and benefits of placebos in antidepressant clinical trials: a decision and cost-effectiveness analysis.

Kim SY, Holloway RG

The American journal of psychiatry.. 2003 July 160 (7):1272-6. Epub 1900 01 01.

Surrogate endpoints in Parkinson's disease research.

Biglan KM, Holloway RG

Current neurology and neuroscience reports.. 2003 July 3 (4):314-20. Epub 1900 01 01.

Development and testing of the Parkinson's disease quality of life scale.

Welsh M, McDermott MP, Holloway RG, Plumb S, Pfeiffer R, Hubble J,

Movement disorders : official journal of the Movement Disorder Society.. 2003 June 18 (6):637-45. Epub 1900 01 01.

A Bayesian argument against rigid cut-offs in electrodiagnosis of median neuropathy at the wrist.

Nodera H, Herrmann DN, Holloway RG, Logigian EL

Neurology.. 2003 February 1160 (3):458-64. Epub 1900 01 01.

Surrogate endpoints in Parkinson's disease research

Biglan,K. M.; Holloway,R. G.;.

Curr.Neurol.Neurosci.Rep. 2003; 3(4): 314-320.

Medical errors on an inpatient neurology service

Frank,S.; Holloway,R.;.

Neurology. 2003; 61(2): 254-257.

Burdens and benefits of placebos in antidepressant clinical trials: a decision and cost-effectiveness analysis

Kim,S. Y.; Holloway,R. G.;.

Am.J.Psychiatry. 2003; 160(7): 1272-1276.

Development and testing of the Parkinson's disease quality of life scale

Welsh,M.; McDermott,M. P.; Holloway,R. G.; Plumb,S.; Pfeiffer,R.; Hubble,J.; Parkinson Study Group;.

Mov.Disord. 2003; 18(6): 637-645.

CT in detecting urinary tract calculi: influence on patient imaging and clinical outcomes.

Gottlieb RH, La TC, Erturk EN, Sotack JL, Voci SL, Holloway RG, Syed L, Mikityansky I, Tirkes AT, Elmarzouky R, Zwemer FL, Joseph JV, Davis D, DiGrazio WJ, Messing EM

Radiology.. 2002 November 225 (2):441-9. Epub 1900 01 01.

Dopamine transporter brain imaging to assess the effects of pramipexole vs levodopa on Parkinson disease progression.

JAMA.. 2002 April 3287 (13):1653-61. Epub 1900 01 01.

Clinical trial end points: on the road to nowhere?

Holloway RG, Dick AW

Neurology.. 2002 March 1258 (5):679-86. Epub 1900 01 01.

A review of pramipexole and its clinical utility in Parkinson's disease.

Biglan KM, Holloway RG

Expert opinion on pharmacotherapy.. 2002 February 3 (2):197-210. Epub 1900 01 01.

A review of pramipexole and its clinical utility in Parkinson's disease

Biglan,K. M.; Holloway,R. G.;.

Expert Opin.Pharmacother. 2002; 3(2): 197-210.

CT in detecting urinary tract calculi: influence on patient imaging and clinical outcomes

Gottlieb,R. H.; La,T. C.; Erturk,E. N.; Sotack,J. L.; Voci,S. L.; Holloway,R. G.; Syed,L.; Mikityansky,I.; Tirkes,A. T.; Elmarzouky,R.; Zwemer,F. L.; Joseph,J. V.; Davis,D.; DiGrazio,W. J.; Messing,E. M.;.

Radiology. 2002; 225(2): 441-449.

Clinical trial end points: on the road to nowhere?

Holloway,R. G.; Dick,A. W.;.

Neurology. 2002; 58(5): 679-686.

Randomized pilot trial of betaINF1a (Avonex) in patients with inclusion body myositis.

Neurology.. 2001 November 1357 (9):1566-70. Epub 1900 01 01.

Randomized, double-blind, placebo-controlled trial of albuterol in facioscapulohumeral dystrophy.

Kissel JT, McDermott MP, Mendell JR, King WM, Pandya S, Griggs RC, Tawil R,

Neurology.. 2001 October 2357 (8):1434-40. Epub 1900 01 01.

Development of performance measures for acute ischemic stroke.

Holloway RG, Vickrey BG, Benesch C, Hinchey JA, Bieber J,

Stroke.. 2001 September 32 (9):2058-74. Epub 1900 01 01.

Deep brain stimulation in the treatment of Parkinson's disease: a cost-effectiveness analysis.

Tomaszewski KJ, Holloway RG

Neurology.. 2001 August 2857 (4):663-71. Epub 1900 01 01.

Initial treatment of early Parkinson's disease: a review of recent, randomized controlled trials.

Biglan K, Holloway RG

Current neurology and neuroscience reports.. 2001 July 1 (4):329-36. Epub 1900 01 01.

Neurologists' use of ICD-9CM codes for dementia.

Pippenger M, Holloway RG, Vickrey BG

Neurology.. 2001 May 856 (9):1206-9. Epub 1900 01 01.

Lawyers, litigation, and liability: can they make patients safer?

Holloway RG, Panzer RJ

Neurology.. 2001 April 2456 (8):991-3. Epub 1900 01 01.

US neurologists: attitudes on rationing.

Holloway RG, Ringel SP, Bernat JL, Keran CM, Lawyer BL

Neurology.. 2000 November 2855 (10):1492-7. Epub 1900 01 01.

A multicenter assessment of dopamine transporter imaging with DOPASCAN/SPECT in parkinsonism. Parkinson Study Group.

Neurology.. 2000 November 2855 (10):1540-7. Epub 1900 01 01.

Pramipexole vs levodopa as initial treatment for Parkinson disease: A randomized controlled trial. Parkinson Study Group.

JAMA.. 2000 October 18284 (15):1931-8. Epub 1900 01 01.

Systematic review of clinical prediction rules for neuroimaging in the evaluation of dementia.

Gifford DR, Holloway RG, Vickrey BG

Archives of internal medicine.. 2000 October 9160 (18):2855-62. Epub 1900 01 01.

Stroke prevention: narrowing the evidence-practice gap.

Holloway RG, Benesch C, Rush SR

Neurology.. 2000 May 2354 (10):1899-906. Epub 1900 01 01.

Cost-effectiveness analysis in Parkinson's disease: determining the value of interventions.

Siderowf AD, Holloway RG, Stern MB

Movement disorders : official journal of the Movement Disorder Society.. 2000 May 15 (3):439-45. Epub 1900 01 01.

Weighing the evidence on DWI: caveat emptor.

Zivin JA, Holloway RG

Neurology.. 2000 April 2554 (8):1552. Epub 1900 01 01.

Employment-seeking experiences of residents in 1996: a window into the neurology marketplace.

Larson WL, Holloway RG, Keran CM

Neurology.. 2000 January 1154 (1):214-8. Epub 1900 01 01.

A randomized controlled trial comparing pramipexole with levodopa in early Parkinson's disease: design and methods of the CALM-PD Study. Parkinson Study Group.

Clinical neuropharmacology.. 2000 23 (1):34-44. Epub 1900 01 01.

Resolution of transient ischemic attacks and aortic arch thrombi on anticoagulant therapy.

Holloway RG, Kantrowitz JT, St James EC, Giang D, Schwarz K

European neurology.. 2000 43 (3):184-5. Epub 1900 01 01.

To test or not to test? That is the question.

Holloway RG, Feasby TE

Neurology.. 1999 December 1053 (9):1905-7. Epub 1900 01 01.

Systematic review of cost-effectiveness research of stroke evaluation and treatment.

Ebrahim S, Holloway RG, Benesch CG

Stroke.. 1999 December 30 (12):2759-68. Epub 1900 01 01.

Neurological outcomes in late HIV infection: adverse impact of neurological impairment on survival and protective effect of antiviral therapy. AIDS Clinical Trial Group and Neurological AIDS Research Consortium study team.

Price RW, Yiannoutsos CT, Clifford DB, Zaborski L, Tselis A, Sidtis JJ, Cohen B, Hall CD, Erice A, Henry K

AIDS.. 1999 September 1013 (13):1677-85. Epub 1900 01 01.

Improving adherence to dementia guidelines through education and opinion leaders. A randomized, controlled trial.

Gifford DR, Holloway RG, Frankel MR, Albright CL, Meyerson R, Griggs RC, Vickrey BG

Annals of internal medicine.. 1999 August 17131 (4):237-46. Epub 1900 01 01.

A randomized trial to implement practice recommendations: design and methods of the Dementia Care Study.

Holloway RG, Gifford DR, Frankel MR, Vickrey BG

Controlled clinical trials. 1999 August 20 (4):369-85. Epub 1900 01 01.

A systematic review of cost-effectiveness research of stroke evaluation and treatment.

Holloway RG, Benesch CG, Rahilly CR, Courtright CE

Stroke.. 1999 July 30 (7):1340-9. Epub 1900 01 01.

US neurologists in the 1990's: trends in practice characteristics.

Holloway RG, Vickrey BG, Keran CM, Lesser E, Iverson D, Larson W, Swarztrauber K

Neurology.. 1999 April 2252 (7):1353-61. Epub 1900 01 01.

Cerebrovascular disease in patients with HIV-1 associated pulmonary hypertension.

Schifitto G, Holloway R

Journal of neuro-AIDS.. 1999 2 (2):57-64. Epub 1900 01 01.

Cost effectiveness of pramipexole in Parkinson's disease in the US.

Hoerger TJ, Bala MV, Rowland C, Greer M, Chrischilles EA, Holloway RG

PharmacoEconomics.. 1998 November 14 (5):541-57. Epub 1900 01 01.

Magnetic resonance imaging in delayed brachial plexopathy following a clavicular fracture.

Holloway RG, Courtright CE, Rahilly CR, Totterman SM, Shrier D

European neurology.. 1998 August 40 (2):105-6. Epub 1900 01 01.

Narrowing the evidence-practice gap. Strengthening the link between research and clinical practice.

Holloway RG, Ringel SP

Neurology.. 1998 February 50 (2):319-21. Epub 1900 01 01.

Carotid endarterectomy trends in the patterns and outcomes of care at academic medical centers, 1990 through 1995.

Holloway RG, Witter DM, Mushlin AI, Lawton KB, McDermott MP, Samsa GP

Archives of neurology.. 1998 January 55 (1):25-32. Epub 1900 01 01.

Economic impact of stoke and implications for interventions

Benesch,C.; Holloway RG;.

CNS Drugs. 1998; 9(1): 29-39.

Reversible symptomatic venous congestion after treatment of dural arteriovenous fistula using NBCA.

Uchino A, Numaguchi Y, Holloway RG, Cherian N

Radiation medicine.. 1998 16 (6):477-81. Epub 1900 01 01.

The cost-effectiveness of magnetic resonance imaging for patients with equivocal neurological symptoms.

Mushlin AI, Mooney C, Holloway RG, Detsky AS, Mattson DH, Phelps CE

International journal of technology assessment in health care.. 1997 13 (1):21-34. Epub 1900 01 01.

Cost-effectiveness analysis: what is it and how will it influence neurology.

Holloway RG

Annals of neurology.. 1996 June 39 (6):818-23. Epub 1900 01 01.

Intracranial mass lesions in acquired immunodeficiency syndrome: using decision analysis to determine the effectiveness of stereotactic brain biopsy.

Holloway RG, Mushlin AI

Neurology.. 1996 April 46 (4):1010-5. Epub 1900 01 01.

Inpatient costs of specific cerebrovascular events at five academic medical centers.

Holloway RG, Witter DM, Lawton KB, Lipscomb J, Samsa G

Neurology.. 1996 March 46 (3):854-60. Epub 1900 01 01.

Cognitive performance and regional brain volume in human immunodeficiency virus type 1 infection.

Kieburtz K, Ketonen L, Cox C, Grossman H, Holloway R, Booth H, Hickey C, Feigin A, Caine ED

Archives of neurology.. 1996 February 53 (2):155-8. Epub 1900 01 01.

Headache and the human immunodeficiency virus type 1 infection.

Holloway RG, Kieburtz KD

Headache.. 1995 May 35 (5):245-55. Epub 1900 01 01.

Structure of the gene for cartilage matrix protein, a modular protein of the extracellular matrix. Exon/intron organization, unusual splice sites, and relation to alpha chains of beta 2 integrins, von Willebrand factor, complement factors B and C2, and epidermal growth factor.

Kiss I, Deák F, Holloway RG, Delius H, Mebust KA, Frimberger E, Argraves WS, Tsonis PA, Winterbottom N, Goetinck PF

The Journal of biological chemistry.. 1989 May 15264 (14):8126-34. Epub 1900 01 01.

Management can reverse declining employee work attitudeoblem solving.

Holloway RG

Hospitals.. 1976 October 1650 (20):71-77. Epub 1900 01 01.

Planning for results and specific outcomes.

Holloway RG

Hospitals.. 1976 May 1650 (10):77-8, 80, 82. Epub 1900 01 01.

The administrator and the future of collective actions.

Holloway RG

A report of the ... National Forum on Hospital and Health Affairs. 1976 :70-83. Epub 1900 01 01.

Work-study career mobility program.

Holloway S, Holloway RG

Hospitals.. 1972 August 1646 (16):73-6. Epub 1900 01 01.

A survey program for management and organizational development.

Holloway RG, Lonergan WG

Hospitals.. 1968 August 1642 (16):59-65. Epub 1900 01 01.

The participation patterns of "economic influentials" and their control of a hospital board of trusties.

HOLLOWAY RG, ARTIS JW, FREEMAN WE

Journal of health and human behavior.. 1963 4 :88-99. Epub 1900 01 01.

Reduction in Health Care Costs After Successful Epilepsy Surgery: Results of a US Multi-center Study.

Langfitt JL, Holloway RG, McDermott MP, Messing S, Sarosky K, Berg AT, Vickrey, BG, Sperling MR, Spencer SS, Bazil CW, and Shinnar S.

Neurology. .

Use of US-Specific EQ-5D Preference Weights: The Implications for the Cost-Effectiveness of Pramipexole.

Noyes K, Dick AW, Holloway RG and the Parkinson Study Group.

Medical Decision Making.

Risk Factors for Somnolence, Edema and Hallucinations in Early Parkinson's Disease.

Biglan KM, Holloway RG, McDermott MP, Richard IR and the Parkinson Study Group CALM-PD Investigators.

Neurology. .

Proactive Palliative Care in the Medical Intensive Care Unit: Reducing Length of Stay.

Norton SA, Hogan L, Holloway R, Temkin Greener H, Buckley M, and Quill TE.

Critical Care Medicine. .

A cost-effectiveness comparison of desirpramine, gabapentin, and pregabalin for treating postherpetic neuralgia.

O'Connor AB, K Noyes, Holloway RG.

JAGS. .

A Clinical Decision Model of Two Disease Modifying Agents for Multiple Sclerosis.

Thompson JP, Noyes K, Dorsey ER, Schwid SR, Holloway RG.

Intl. J. of Technology Assessment in Health Care.

Mortality as a measure of quality: implications for palliative and end-of-life care.

Holloway RG, Quill TE.

JAMA. .

Books

Andreoli and Carpenter's Cecil Essentials of Medicine (2010)

Chapter: Palliative Care

Authors: Holloway R.G., Quill T.E

Publisher: Elsevier, Philadelphia 2010

Parkinson's Disease (2005)

Chapter: Economics of Parkinson's Disease

Authors: Noyes K and Holloway RG

Publisher: CRC Press, Boca Raton 2005

Neuroepidemiology: From Principles to Practice, (2004)

Chapter: Evidence-based medicine

Authors: Holloway RG, Vickrey BG, Thom DH.

Publisher: Oxford University Press, Oxford 2004

Neuroepidemiology: From Principles to Practice (2004)

Chapter: Health Services Research in Neurology

Authors: Holloway RG, Vickrey BG

Publisher: Oxford University Press, Oxford 2004

Neurological Therapeutics: Principles and Practice (2003)

Chapter: Evidence-based medicine

Authors: Vickrey BG, Holloway RG.

Publisher: London, UK., Martin Dunitz Ltd. 2003

The Prevention of Stroke (2002)

Chapter: Quality improvement in stroke prevention

Authors: Holloway RG, Rush SR.

Publisher: The Parthenon Publishing Group, New York 2002

Prognosis of Neurological Disorders (2000)

Chapter: Economic prognosis: evaluating economic outcomes of health care.

Authors: Langfitt JT, Holloway RG:

Publisher: Oxford University Press, New York 2000

Baker's Clinical Neurology (2000)

Chapter: Current Therapy

Authors: Blindauer KA, Benesch CG, Counihan T, Schwid SR, Toczek M, Wollman E, Holloway RG, Kieburtz K.

Publisher: Lippincott, Williams, and Wilkins Publishers, Philadelphia 2000

Parkinson's Disease Diagnosis and Clinical Management (2000)

Chapter: Economic impact of Parkinson's Disease: implications for interventions.

Authors: Siderowf A, Holloway RG.

Publisher: Demos Medical Publishing, Inc. 2000

Case Studies in Neuroscience (1999)

Authors: Jozefowicz RF, Holloway RG

Publisher: F.A. Davis Company, Philadelphia, PA 1999

Principles and Practice of Infectious Diseases (1998)

Chapter: Neurologic Manifestations of HIV Infection

Authors: Holloway RG, Kieburtz K

Publisher: W.B. Saunders Company, New York, NY 1998

Clinical Neurology (1996)

Chapter: HIV-1 infection and the nervous system

Authors: Holloway RG, Kieburtz KD, Schiffito G

Publisher: JB Lippincott, Philadelphia, PA 1996

Clinical Neurology (1996)

Chapter: Current Therapy

Authors: Goodman A, Benesch CG, Berg M, Calabresi PA, Dimitsopulos T, Holloway RG, Samuels O, Joynt RJ, Williams L, Wojcieszek J

Publisher: JB Lippincott, Philadelphia, PA 1996

Neurobase (1995)

Chapter: Headache associated with Acquired Immune Deficiency Syndrome

Authors: Holloway RG, Kieburtz KD

Publisher: Arbor Publishing Corp, La Jolla, CA 1995

Clinical Neurology (1995)

Chapter: Current Therapy

Authors: Jozefowicz RF, Benesch CG, Berg M, Calabresi PA, Dimitsopulos T, Goodman A, Holloway RG, Joynt RJ, Williams L, Wojcieszek J

Publisher: JB Lippincott,, Philadelphia, PA 1995

Ratings & Comments

At URMC, we believe that patients should be empowered to make the right decisions regarding their personal healthcare. To do so, transparency is critical. URMC partners with Press Ganey, to survey our patients about all aspects of their care experience. We are now putting this pertinent information at your fingertips by displaying star ratings for our providers along with anonymous patient comments on our website. This will help you make better-informed choices about how and with whom you seek care. Click here to learn more about the surveys used to generate this vital information. Learn more about our survey process.

Ratings

During this visit, did this provider spend enough time with you?

4.9

During this visit, did this provider show respect for what you had to say?

4.8

During this visit did this provider give you easy to understand information about these health questions or concerns?

4.9

During this visit, did this provider listen carefully to you?

4.8

During this visit, did this provider explain things in a way that was easy to understand?

4.8

Patient Comments

Listened closely to concerns

Aug 30, 2024

5.0

Doctor Holloway was extremely kind and open to my concerns at my visit.

May 15, 2024

5.0

Highly impressed - he is VERY good at listening - addressing all/any questions & very nice!

May 02, 2024

5.0

Dr. Holloway was friendly, courteous, and checked with colleagues re: a medication he wanted to put me on.

Dec 18, 2023

5.0

Most through exam I ever had. Dr. Holloway is by far one of the best doctors ever who treated me.

Aug 22, 2023

5.0

Dr. Holloway was very thorough in the exam & explained everything in easy to understand terms.

Aug 14, 2023

5.0

Dr. Holloway is a very kind, caring person. He treated me respectfully & thoughtfully & engaged me in the whole assessment process & treatment decisions.

May 13, 2022